INVESTORS & MEDIA
SEC Filing Details
SEC Filing Details
Document Details
Form
Filing Date
Feb 2, 2024
Document Date
Jan 31, 2024
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
Regeneron Pharmaceuticals Inc.
Issuer
REGENERON PHARMACEUTICALS, INC.
Filer
Landry Robert E